(Q39662626)

English

A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness

scientific article published on March 22, 1979

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.1007/BF00426739

https://api.crossref.org/works/10.1007/BF00426739

25 November 2022

author name string

J. P. Feighner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

B. Brauzer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

A. J. Gelenberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

E. Gomez

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

A. Kiev

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

M. L. Kurland

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

B. L. Weiss

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A108739

26 April 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=108739

26 April 2022

publication date

1 March 1979

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

22 March 1979

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=108739

26 April 2022

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00426739.pdf

Portable Document Format

1 reference

10.1007/BF00426739

https://api.crossref.org/works/10.1007/BF00426739

25 November 2022

http://link.springer.com/article/10.1007/BF00426739/fulltext.html

1 reference

10.1007/BF00426739

https://api.crossref.org/works/10.1007/BF00426739

25 November 2022

http://link.springer.com/content/pdf/10.1007/BF00426739

1 reference

10.1007/BF00426739

https://api.crossref.org/works/10.1007/BF00426739

25 November 2022

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

217-225

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A comparative trial of Ro 4-6270 and amitriptyline in depressive illness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reflections on the Specificity of Action of Anti-Depressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of imipramine plasma levels for depressive illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy: patient compliance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of chlordiazepoxide-amitriptyline combination with amitriptyline alone in anxiety-depressive states.

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment in depressive illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentration of amitriptyline and clinical response

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fault and Default

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of methaminodiazepoxide (chlordiazepoxide, "Librium") in the treatment of anxiety in neurotic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential drug effects in neurotic depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/108739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00426739

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39662626&oldid=2203066434"